Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Repligen Corp shares valued at $3,508,389 were sold by Hunt Anthony on Sep 10 ’25. At $120.52 per share, Hunt Anthony sold 29,111 shares. The insider’s holdings dropped to 100,743 shares worth approximately $12.03 million following the completion of this transaction.
Also, Hunt Anthony purchased 29,111 shares, netting a total of over 3,508,378 in proceeds.
Before that, Madaus Martin D had added 1,800 shares to its account. In a trade valued at $201,830, the Director bought Repligen Corp shares for $112.13 each. Upon closing the transaction, the insider’s holdings increased to 1,800 shares, worth approximately $0.21 million.
Analysts at Barclays started covering the stock with ‘”an Overweight”‘ outlook in a report released in late June. As of April 29, 2025, Wolfe Research has increased its “Peer perform” rating to a “an Outperform” for RGEN. Earlier on March 18, 2025, Evercore ISI initiated its rating. Their recommendation was “an In-line” for RGEN stock.
Analyzing RGEN Stock Performance
On last trading session, Repligen Corp [NASDAQ: RGEN] plunged -0.30% to $119.39. The stock’s lowest price that day was $117.14, but it reached a high of $122.9 in the same session. During the last five days, there has been a drop of approximately -0.70%. Over the course of the year, Repligen Corp shares have dropped approximately -14.72%.
Is Repligen Corp subject to short interest?
Stocks of Repligen Corp saw a sharp steep in short interest on 2025-08-29 dropping by 12738.0 shares to 3.62 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 3.64 million shares. A decline of -0.35% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.3 of the overall float, the days-to-cover ratio (short ratio) decline to 4.3.
Which companies own the most shares of Repligen Corp (RGEN)?
In terms of Repligen Corp share price expectations, FactSet research, analysts set an average price target of 205 in the next 12 months, up nearly 71.19% from the previous closing price of $119.75. Analysts anticipate Repligen Corp stock to reach 205 by 2025, with the lowest price target being 205. In spite of this, 9 analysts ranked Repligen Corp stock as Buy at the end of 2025. On February 10, 2025, TD Cowen assigned a price target of “a Buy” to the stock and initiated coverage with a $200.
